Featured Article

Featured Article

2023 JDD Welcome Kit

The Journal of Drugs in Dermatology (JDD) and its sponsors are welcoming the latest dermatology residency graduates into the specialty. Graduates from 2023 are each receiving a JDD Welcome Kit. This toolbox of samples and information allows new dermatologists to test products first-hand before considering them for their patients.

“We strive to help new graduates experience first-hand the products that are available to their patients, and we are thankful for our sponsors who are educating and preparing new dermatologists,” said Luciana Halliday Nofal, vice president, proprietary conferences and SanovaWorks, at MedscapeLIVE!, which produces the JDD, along with ODAC, Derm In-Review, Next Steps in Derm and The Full Spectrum Of Dermatology: A Diverse and Inclusive Atlas.

Supporters who participated in the JDD Welcome Kit include:

Developed with dermatologists, CeraVe is designed to help repair and strengthen the skin’s natural barrier, reinforcing healthy skin for all. We are proud of our dermatology heritage and partnership, and are now the #1 dermatologist recommended skincare brand in the U.S.

We partner with dermatologists to stay at the forefront of skincare science, pioneering cutting-edge topics like skin’s microbiome. With over 750+ studies on more than 200,000 patients of all skin tones, ages and ethnicities, we are committed to developing safe and effective products that are dermatologist developed and tested.

SkinCeuticals mission is to improve skin health. Dedicated to this purpose, we make one simple promise—to provide advanced skincare backed by science. Made in the USA, our clinical skincare is formulated to correct signs of aging, protect healthy skin, and prevent future damage.

 

VICHY Laboratoires is a doctor-founded skincare brand with 90+ years of scientific expertise. We are committed to skin health science, empowering individuals to maximize skin health at every life stage. Recommended by dermatologists worldwide, our products promise efficacy and safety.

skinbetter science stands firm in our commitment to physician exclusivity and partnership focused business practices. We are the only brand that share in the proceeds of each and every unit of skinbetter product sold with our Physician Partners.

Our groundbreaking science transforms nature’s ingredients into clinically proven products that help soothe, strengthen, and restore the moisture barrier. Our ingredients—uniquely formulated to optimize skin health—are supported by 75 years of published data. Visit AveenoMD.com to learn about new products, patient resources and samples.

For over 90 years, Neutrogena® has made sophisticated science simple, delivering solutions that balance clinical efficacy with premium aesthetics. Neutrogena® aims to demystify skin science and help patients better understand their skin’s vital functions. Our scientists study skin from the outside in and the inside out to formulate products that protect and nourish the skin. Visit NeutrogenaMD.com – dedicated to dermatology professionals.

Cetaphil has been partnering with dermatologists for over 75 years to formulate products specifically for your sensitive skin patients. Cetaphil products have been tested on more than 32,000 patients across 550 clinical studies to ensure a gentle and efficacious experience.

TIZOÒ is dedicated to creating mineral photoprotection and skincare that is both highly efficacious and exceptionally elegant. TIZO mineral sunscreens are lightweight, virtually invisible on skin, and 100% free of chemical sunscreen filters, dyes, fragrances, gluten, preservatives and phthalates. Reef-friendly.

Beiersdorf is a global leader in therapeutic skin care products. Visit our website, www.BeiersdorfMD.com to learn about our innovations along with our existing EucerinÒ & AquaphorÒ Products. Our goal is to develop therapeutic skin care products that are trusted by healthcare professionals and recommended to their patients every day.

For 30 years, PCA SKINÒ has pioneered and perfected the science of skin health. We create individualized solutions to deliver dramatic, visible results, starting with our transformative professional peels. Our professional peel treatments bring effective skincare solutions into the future, ensuring the best results.

EltaMD knows you’re with your skin for life, so you need skincare that is, too. At EltaMD, we make professional sun and skin care that’s loved by skin and trusted by Dermatologists. In fact, EltaMD isn’t just the #1 Dermatologist-recommended professional sunscreen brand; it’s the brand they most trust and personally use.

The leader in hair science and innovation, Nutrafol’s daily hair growth Nutraceuticals have been shown to improve hair growth and reduce shedding in multiple clinical studies, and are the #1 dermatologist recommended hair growth supplement brand for trusted, reliable results. http://nutrafol.com/professionals

The JDD Welcome Kits were mailed to 2023 residency program graduates in late 2023. Companies interested in participating in future welcome kits should contact the JDD Sales Team at sales@jddonline.com.

The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by dermatologist Perry Robins, MD. Celebrating more than 20 years of educating dermatologists, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology, which provide readers with peer-reviewed content of the utmost quality. The JDD is overseen by an International Editorial Board of more than 160 renowned experts and reaches more than 30,000 dermatology healthcare practitioners worldwide.

You May Also Like

JDD in the News: Efficacy and Tolerability of Stabilized, Bioactive Retinol

| Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
by Allison Sit Dermatology Times, HAPPI, Healio and HealthDay all wrote about an April article in the Journal of Drugs in Dermatology that was one of one of the largest,…

JDD in the News: Cysteamine Isobionic-Amide Complex for Melasma

| Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, Melasma, The Latest | No Comments
by Allison Sit Dermatology Advisor, Dermatology Times and Healio all covered recent articles in the Journal of Drugs in Dermatology. One study, “Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the…

JDD in the News: Topical Clascoterone Efficacy Increases Over Time for Acne

| Acne, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
by Allison Sit Dermatology Advisor, Dermatology News, Healio, Medriva and Medscape all covered a Journal of Drugs in Dermatology study about the long-term safety and effectiveness of topical clascoterone for…

Leave a Reply